Amphipathic Tail-Anchoring Peptide is a Promising Therapeutic Agent for Cancer Treatment  by De, Gejing et al.
186a Sunday, February 16, 2014shows distinct state 2, 3 and 4 respiration, which can be mimicked in E9.5 WT
hearts by incubation with 200 nM CsA. By E11.5 mitochondrial oxygen con-
sumption in WT hearts is not significantly different when compared to E11.5
CypD KO mice or E13.5 hearts.
In addition, supercomplexes were not detectable in WT hearts of E9.5 and
E11.5 embryos by native electrophoresis or immunocapturing. This may
explain why NADH-cytochrome c reductase activity is not detectable in WT
embryos at E9.5 but in E11.5 or E13.5 WT mice. Furthermore, Cx-1 is in its
de-active form at E9.5 and becomes activated around E11.5.
Our data suggests that at E11.5 the PTP is closed and Cx-1, Cx- 2 and Cx-3 of
the ETC are present, but are not yet arranged in supercomplexes and a coordi-
nated electron transfer is still developing.
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Parkinson’s disease (PD) is one of the most prevalent neurodegenerative disor-
ders, characterized by loss of dopaminergic neuron function; leading to brady-
kinesia andmotor dysfunction. It is observed that various geneswhich have been
implicated in the familial and sporadic forms of the disease are involved in path-
ways which focalize at the mitochondria. This organelle is a central regulator of
cell death, and mitochondrial dysfunction is a common phenomenon associated
with multiple neurodegenerative diseases. Not surprisingly, a clinical screen
identified PD-associated mutations in mitochondrial Hsp70 (mtHsp70), which
is a critical protein involved in mitochondria biogenesis and maintenance of ho-
meostasis. In order to specifically understand the role of the mtHsp70 protein,
we have developed a Saccharomyces cerevisiaemodel for studying the disease
variants in isolation from other players of this multifactorial disease. We gener-
ated the analogousmutants R103W and P486S in yeast mtHsp70 which remark-
ably recapitulated the symptoms of mitochondrial dysfunction in affected
neurons including cell death, increased generation of ROS,mtDNA loss and res-
piratory incompetence. Spectral analysis of a fluorescent carbocyanine dye up-
take in isolated mitochondria indicated compromised membrane potential
gradients as a cause for dysfunction. At the molecular level, circular dichroism
based-thermal melt analyses confirmed the observed in vivo aggregation pro-
pensity of R103W, while P486S exhibited futile enhanced interaction with J-
protein co-chaperone partners thereby resulting in loss of chaperoning activity
by mtHsp70. Remarkably, these altered biochemical properties reflect identical
defects found by us in the human mtHsp70 variants, thereby confirming a direct
involvement of mtHsp70 in PD progression. Thus, by utilizing the significant
structural and functional homology between the yeast and human mtHsp70 pro-
teins, and an integrated in vivo and in vitro approach, we demonstrate the basic
underlying mechanisms of mtHsp70 association with PD.
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The amphipathic tail-anchoring peptide (ATAP) derived from the human anti-
apoptotic protein Bfl-1 is a potent inducer of apoptosis by targeting mitochon-
dria permeability transition. By linking ATAP to an internalizing RGD peptide
(iRGD), selective targeting for ATAP to tumor cells could be achieved. Target-
ing of ATAP-iRGD peptide to tumorigenic cells resulted in mitochondrion-
dependent cell death through release of cytochrome c. Confocal fluorescence
microscopy showed that Dylight488-labeled ATAP-iRGD could effectively
penetrate into cells and distribute along the mitochondria network. Flow cytom-
etry results showed that expression level of integrinaV or integrinaVb3 recep-
tors is higher in ATAP-iRGD sensitive (DU145, KYSE-150 and PC3) cells,
when compared with ATAP-iRGD insensitive (K562 human leukemia cell)
cell line. These results indicate that integrins act as a receptor to mediate uptake
of ATAP-iRGD into the cancer cells. Studies with xenograft model showed that
intravenous injection of ATAP-iRGD could suppress the growth of several hu-
man carcinoma cells implemented into the nude mice. Toxicological studies re-
vealed that repetitive intravenous delivery of ATAP-iRGD did not produce
significant toxicity in different organs of the SV129 mice. Our data suggestthat ATAP-iRGD is a promising agent with high efficacy and limited toxicity
for cancer therapy.
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Myosin II inhibitor Blebbistatin is frequently used for heart immobilization
during imaging experiments involving ischemia/reperfusion (I/R). Here we
investigated the extent to which Blebbistatin modulates critical events during
I/R, such as mitochondrial membrane potential depolarization (DJm), asystole,
and infarction. Langendorff-perfused rabbit hearts were subjected to 60-90 mi-
nutes of ischemia and 180 minutes of reperfusion in the absence (control) or in
the presence of Blebbistatin (5.7 mM). We monitored DJm depolarization
using spectral analysis of confocal images yielded by cationic fluorescent
dye TMRM. We detected the onset of sarcolemmal permeabilization (SP) in
individual myocytes as a massive uptake of anionic dye DiBac4(3) or cell-
impermeable nucleic acid dye YO-PRO1. Control hearts were briefly perfused
with 20 mM potassium at 35 minutes prior to ischemia, and at 30 and 120 mi-
nutes of reperfusion to achieve immobilization necessary for confocal imaging.
In control hearts, cessation of contraction permitted confocal imaging after
10-15 minutes of ischemia. Global and local bipolar electrograms monitored
electrical activity. During ischemia, Blebbistatin significantly (p<0.01) and
proportionally delayed both DJm depolarization (50.5 minutes versus
24.0 minutes in control) and asystole (40.2 minutes versus 22.3 minutes in con-
trol). Upon reperfusion, a heterogeneous DJm recovery was observed in both
groups, but Blebbistatin largely prevented SP events observed on a massive
scale in control hearts. Additionally, Blebbistatin almost completely prevented
infarction in this model (1.953.2% versus 75.057.8% in control by tetrazo-
lium chloride staining). Another electromechanical uncoupler, 2,3-Butane-
dione monoxime (20 mM), did not prevent SP and infarction despite efficient
immobilization. Conclusions: (1) great caution has to be exercised with regard
to interpretation of I/R events observed in the presence of Blebbistatin; (2) the
mechanism(s) of prominent cardioprotection by Blebbistatin may not be fully
explained by immobilization and deserve further study.
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The aim of this work is to study structural and functional organization of energy
metabolism in an ex vivo model of myocardial ischemia-reperfusion, focusing
on the role of mitochondria interactions with cytoskeletal proteins in the regu-
lation of mitochondrial respiration and dynamics. Hearts studied were sub-
jected to perfusion under normoxic, ischemia and ischemia-reperfusion
conditions using Langendorff system.
Hemodynamic measurements showed that reperfusion-dependent left ventricu-
lar diastolic dysfunction is related to increased affinity of respiration for ADP
(low app. Km for ADP). This loss of ADP microcompartmentalization was
associated with decreased functional coupling between oxidative phosphoryla-
tion and mitochondrial creatine kinase. Previous studies have shown that in
healthy adult cardiomyocytes, characterized by high apparent Km for ADP,
cytoskeletal protein b2 tubulin co-localises with mitochondria. Ischemia-
reperfusion injury induces the displacement of b2 tubulin from mitochondrial
position in cardiac muscle fibers with low apparent Km for ADP.
We conclude that ischemia-reperfusion effects on mitochondrial respiration
and dynamics could be related to the disruption of mitochondrial outer mem-
brane porin, VDAC, interaction with cytoskeletal proteins such as b2 tubulin.
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The critical events determining cell death in the aftermath of myocardial
ischemia/reperfusion (I/R) remain poorly understood. Here we investigated
